Citius Oncology (CTOR) Stock Chart & Stock Price History $0.98 -0.08 (-7.73%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsTrends Citius Oncology Stock Price Performance 5 Day Performance-11.88%1 Month Performance+14.79%3 Month Performance-38.87% Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… CTOR Stock Chart for Sunday, December, 22, 2024 CTOR Chart by TradingView Citius Oncology Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$1.06$0.98-7.73%$1.09$0.97182,268 shs$2.30 million12/19/2024$1.00$1.06+6.00%$1.11$0.95186,603 shs$2.50 million12/18/2024$1.11$1.00-9.91%$1.12$1.00112,738 shs$2.36 million12/17/2024$1.10$1.11+0.91%$1.20$1.06128,786 shs$2.62 million12/16/2024$1.11$1.10-0.90%$1.13$1.07129,731 shs$2.60 million12/13/2024$1.07$1.11+3.74%$1.12$1.0759,622 shs$2.62 million Get the Latest News and Ratings for CTOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$1.08$1.07-0.93%$1.11$1.05100,374 shs$2.52 million12/11/2024$1.10$1.08-1.82%$1.20$1.08146,224 shs$2.54 million12/10/2024$1.18$1.10-6.78%$1.19$1.02270,667 shs$2.59 million12/09/2024$1.44$1.18-18.06%$1.41$1.10727,566 shs$2.79 million12/06/2024$1.62$1.44-11.11%$1.83$1.38573,417 shs$3.39 million12/05/2024$1.41$1.62+14.89%$1.73$1.371.53 million shs$3.82 million12/04/2024$1.46$1.41-3.42%$1.62$1.311.98 million shs$3.33 million12/03/2024$1.02$1.46+43.14%$2.33$1.14101.63 million shs$3.45 million12/02/2024$0.92$1.02+10.98%$1.28$0.905.20 million shs$2.40 million11/29/2024$0.94$0.92-2.24%$1.00$0.9039,791 shs$2.17 million11/28/2024$0.94$0.94$1.07$0.9170,266 shs$2.22 million11/27/2024$1.00$0.94-5.59%$1.07$0.9170,266 shs$2.22 million11/26/2024$0.85$1.00+17.15%$1.00$0.85106,108 shs$2.35 million11/25/2024$0.85$0.85-0.23%$0.91$0.8592,403 shs$2.01 million11/22/2024$0.98$0.85-12.69%$1.01$0.8588,955 shs$2.01 million11/21/2024$0.99$0.98-1.42%$1.03$0.9634,888 shs$2.30 million Related Companies Jaguar Health Stock Chart Indaptus Therapeutics Stock Chart Cellectar Biosciences Stock Chart Cyclerion Therapeutics Stock Chart Mainz Biomed Stock Chart Eagle Pharmaceuticals Stock Chart Vaccinex Stock Chart RedHill Biopharma Stock Chart Apollomics Stock Chart Mustang Bio Stock Chart Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTOR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
